Literature DB >> 2846892

Genetic structure and function of an early transcript of visna virus.

V Mazarin1, I Gourdou, G Quérat, N Sauze, R Vigne.   

Abstract

During the early step of the lytic cycle, visna provirus is first transcribed into two small multispliced mRNAs of 1.6 and 1.2 kilobases which may encode factors regulating the replication of visna virus (R. Vigne, V. Barban, G. Quérat, V. Mazarin, I. Gourdou, and N. Sauze, Virology 161:218-227, 1987). By cDNA cloning and nucleotide sequencing, we determined that the 1.2-kilobase mRNA is 1,174 nucleotides long without the 3'-polyadenylated tail and is composed of four exons, two of which originated from the 5' and 3' ends, respectively, of the env gene region. Two overlapping open reading frames are present in each of these two exons. They were translated in vitro and gave rise to three proteins, two of 19 and 17 kilodaltons, termed VEP1, and one of 16.5 kilodaltons, termed STM. Only the VEP1 proteins were recognized by a hyperimmune anti-visna virus serum of infected sheep. Transient-expression assays performed in eucaryotic cells demonstrated that the cDNA clone described here has a trans-acting effect on transcription of the visna virus genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846892      PMCID: PMC253606     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

Authors:  P Sonigo; M Alizon; K Staskus; D Klatzmann; S Cole; O Danos; E Retzel; P Tiollais; A Haase; S Wain-Hobson
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

3.  A second post-transcriptional trans-activator gene required for HTLV-III replication.

Authors:  J Sodroski; W C Goh; C Rosen; A Dayton; E Terwilliger; W Haseltine
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

4.  Regulation of AIDS virus expression.

Authors:  I S Chen
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

Review 5.  Pathogenesis of lentivirus infections.

Authors:  A T Haase
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

6.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

7.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Nucleotide sequence and transcriptional activity of the caprine arthritis-encephalitis virus long terminal repeat.

Authors:  J L Hess; J M Pyper; J E Clements
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

9.  Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.

Authors:  M A Gonda; F Wong-Staal; R C Gallo; J E Clements; O Narayan; R V Gilden
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

10.  cis- and trans-acting transcriptional regulation of visna virus.

Authors:  J L Hess; J E Clements; O Narayan
Journal:  Science       Date:  1985-08-02       Impact factor: 47.728

View more
  13 in total

1.  Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus.

Authors:  M S Oberste; J D Greenwood; M A Gonda
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.

Authors:  R Rosin-Arbesfeld; M Rivlin; S Noiman; P Mashiah; A Yaniv; T Miki; S R Tronick; A Gazit
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

3.  The open reading frame ORF S3 of equine infectious anemia virus is expressed during the viral life cycle.

Authors:  E Saman; K Breugelmans; L Heyndrickx; J Merregaert
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  Visna virus encodes a post-transcriptional regulator of viral structural gene expression.

Authors:  L S Tiley; P H Brown; S Y Le; J V Maizel; J E Clements; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Pattern of transcription of the genome of equine infectious anemia virus.

Authors:  S Noiman; A Yaniv; L Sherman; S R Tronick; A Gazit
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Two species of Rev proteins, with distinct N termini, are expressed by caprine arthritis encephalitis virus.

Authors:  A Gazit; P Mashiah; H Kalinski; A Gast; R Rosin-Abersfeld; S R Tronick; A Yaniv
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.

Authors:  S Schwartz; B K Felber; D M Benko; E M Fenyö; G N Pavlakis
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Characterization of bovine immunodeficiency virus rev cDNAs and identification and subcellular localization of the Rev protein.

Authors:  M S Oberste; J C Williamson; J D Greenwood; K Nagashima; T D Copeland; M A Gonda
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein.

Authors:  C E Beisel; J F Edwards; L L Dunn; N R Rice
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.

Authors:  S Y Kim; R Byrn; J Groopman; D Baltimore
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.